Nyrada Inc.
ASX: NYR.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James Bonnar
- Employees
- 1
- Headquarters
- Gordon, Australia
- IPO year
- 2020
- Market cap
- A$111.8M
- Website
- https://www.nyrada.com
Loading NYR…
Loading profile data…Frequently asked questions about NYR
What does Nyrada Inc. (NYR.AX) do?
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unab...
Where does NYR.AX trade?
Nyrada Inc. (NYR.AX) trades on the Australian Securities Exchange.
What sector is NYR.AX in?
Nyrada Inc. (NYR.AX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nyrada Inc.?
James Bonnar is the chief executive officer of Nyrada Inc. (NYR.AX).
Where is Nyrada Inc. headquartered?
Nyrada Inc. is headquartered in Australia.
Does NYR.AX pay a dividend?
Nyrada Inc. (NYR.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NYR.AX go public?
Nyrada Inc. (NYR.AX) completed its initial public offering in 2020.